biote Corp. BTMD
0.89 USD -0.10 (-10.51%)
Regular-session close
0.89 0.00 +0.45%
After hours · Nov 18, 5:59 PM ET
0.8804 Day range 1.00
0.8804 52-week range 2.90
- YTD
- -65.92%
- 1 year
- -64.42%
News
fool.com biote: 3 Key Takeaways for Long-Term Investors Biote expects full-year 2026 revenue above $175 million. Third-quarter procedure revenue declined 15.1% year over year to $28.9 million.
seekingalpha.com biote Corp. (BTMD) Q3 2026 Earnings Call Transcript biote Corp. ( BTMD ) Q3 2026 Earnings Call November 4, 2026 5:00 PM EST Company Participants Robert Peterson - Interim CEO, CFO & Chief Business Officer Conference Call Participants Szymon Serowiecki…
zacks.com biote Corp. (BTMD) Tops Q3 Earnings Estimates biote Corp. (BTMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to earnings of $0.22 per share a year ago.
benzinga.com Biote Q3 2026 Earnings Call Transcript Biote (NASDAQ:BTMD) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
businesswire.com Biote Reports Third Quarter 2026 Financial Results IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today…
defenseworld.net Head-To-Head Survey: The Pennant Group (NASDAQ:PNTG) vs. biote (NASDAQ:BTMD) biote (NASDAQ: BTMD - Get Free Report) and The Pennant Group (NASDAQ: PNTG - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two…
businesswire.com Biote Schedules Third Quarter 2026 Financial Results Release and Conference Call IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our…
defenseworld.net biote (NASDAQ:BTMD) and Elevance Health (NYSE:ELV) Head to Head Review Elevance Health (NYSE: ELV - Get Free Report) and biote (NASDAQ: BTMD - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the…
seekingalpha.com biote Corp. (BTMD) Q2 2026 Earnings Call Transcript biote Corp. (BTMD) Q2 2026 Earnings Call Transcript
zacks.com biote Corp. (BTMD) Reports Break-Even Earnings for Q2 biote Corp. (BTMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.1 per share a year ago.
marketbeat.com biote Q2 Earnings Call Highlights biote NASDAQ: BTMD reported lower second-quarter revenue and a net loss as a voluntary recall of certain hormone pellets supplied by Asteria Health disrupted procedure volumes, while management said…
businesswire.com Biote Reports Second Quarter 2026 Financial Results IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today…
businesswire.com Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our…
businesswire.com Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer IRVING, Texas--(BUSINESS WIRE)--Biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) today announced the appointment of Komal Bajaj, MD, MS, as Chief Medical Officer, effective June 1, 2026. Dr.…
gurufocus.com Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO [url="]Biote[/url] (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' pa
businesswire.com Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today…
seekingalpha.com biote Corp. (BTMD) Q1 2026 Earnings Call Transcript biote Corp. (BTMD) Q1 2026 Earnings Call Transcript
zacks.com biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago.
businesswire.com Biote Reports First Quarter 2026 Financial Results IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today…
businesswire.com Biote Schedules First Quarter 2026 Financial Results Release and Conference Call IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our…
seekingalpha.com biote Corp. (BTMD) Q4 2025 Earnings Call Transcript biote Corp. (BTMD) Q4 2025 Earnings Call Transcript
